Amplia CEO Dr Chris Burns and long-time scientific collaborator Professor Andrew Wilks awarded the 2024 Prime Minister’s ...

Technology is disrupting traditional medical practices, with locally listed companies at forefront of innovation including ...

Argonaut slaps buys across the ASX gold sector, with analysts Hayden Bairstow and Patrick Streater tipping bullion to hit ...

ASX 200 ticks up to lunch time on the back of decent Wall Street performance. Telcos, Discretionary and Utilities stocks in ...

Special Report: Vertex Minerals has raised $2.1m following firm commitments for a placement and convertible loan, allowing ...

Rio Tinto and Arcadium both have their reasons for pursuing a $10 billion deal that placed long term faith in the struggling ...

Stockhead’s Sarah Hughan sits down with Great Southern Mining (ASX:GSN) managing director Matt Keane to get the short end of ...

Wall Street rally boosts sentiment as Nvidia jumps 4pc. China’s CSI 300 index falls 5pc amid doubts over stimulus plans.

GreenX wins $490m compensation against Polish government, South HARZ gets $450,000 to realise Euro Potash dream and ...

Experts tell Stockhead what investors can expect for remainder of 2024 as global markets are shaped by a range of powerful ...

With Singaporean approval ticked off for its Remplir nerve-repair product, Orthocell's next step is US approval.

Small resources stocks have been drained as capital flowed into big tech, but a new rate cutting cycle could inject life back ...